Filing Details

Accession Number:
0001493152-22-019731
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-07-18 17:09:00
Reporting Period:
2022-07-14
Accepted Time:
2022-07-18 17:09:00
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1873835 Immix Biopharma Inc. IMMX Pharmaceutical Preparations (2834) 454869378
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1904837 Sean Senn C/O Immix Biopharma, Inc.
11400 West Olympic Blvd., Suite 200
Los Angeles CA 90064
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2022-07-14 200 $2.75 899,800 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct